BIO-TECHNE Corp — Director's Dealing 2024

Feb 5, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2024-02-01

Reporting Person: McManus Matthew (President - DGS)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-02-01	Restricted Stock Units	$	A	2888	Acquired		Common Stock (2888)	Direct
2024-02-01	Restricted Stock Units	$	A	13861	Acquired		Common Stock (13861)	Direct
2024-02-01	Stock Option (Right to Buy)	$68.54	A	7951	Acquired	2031-02-01	Common Stock (7951)	Direct
2024-02-01	Stock Option (Right to Buy)	$68.54	A	15902	Acquired	2031-02-01	Common Stock (15902)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

F2: Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F3: 4,620 restricted stock units vest on 2/1/2025 and 2/1/2027, and 4,621 restricted stock units vest on 2/1/2026.

F4: Options to purchase 3,976 shares vest on 2/1/2025 and 2/1/2027, and options to purchase 3,975 shares vest on 2/1/2026 and 2/1/2028.